STAT+: More hospital and outpatient visits expected to persist through fall and winter
Health care providers and health insurance companies are closing the books on their third quarters,…
Category: Medicine
Can the world still invent an HIV vaccine? Progress in one area creates new problem
Louis Picker is nervous. Last month, the first volunteer was injected with an HIV vaccine…
Bracing for rough respiratory virus season, European officials urge vaccination
LONDON — Health officials in the U.K. and Europe are ramping up their campaigns urging…
STAT+: New lawsuit highlights another wrinkle for settling disputes over surprise medical bills
After Congress officially outlawed surprise medical bills last year, there’s been endless, litigious debate as…
STAT+: Cigna to pay $172 million in Medicare Advantage fraud settlement
Health insurer Cigna is paying more than $172 million to settle allegations that it committed…
STAT+: J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries
In an unexpected turnabout, Johnson & Johnson announced it would not enforce any of its…
GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?
Next week, 50 medical experts from the Karolinska Institutet in Stockholm will meet to award…
Dianne Feinstein’s struggle with shingles reflects the long increase in cases
The trailblazing life of Senator Dianne Feinstein of California, who died on Friday, covers nearly…
STAT+: Court allows Medicare drug price negotiation to proceed
WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to…
STAT+: FDA seeks to regulate lab-developed tests, closing the ‘Theranos loophole’
The Food and Drug Administration on Friday announced its intention to start regulating tests developed…
STAT+: Unitaid slams J&J over pricing and patents for a tuberculosis drug
In a highly unusual move, Unitaid has publicly criticized Johnson & Johnson over its pricing…
.jpg)
STAT+: Generic makers fall short when providing access to low- and middle-income countries, analysis finds
A handful of the largest purveyors of generic medicines have made only halting progress to…
STAT+: Sales from controversial drug discount program rose to $54 billion last year
Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $53.7…
WHO recommends dropping component of many flu vaccines
The World Health Organization has recommended dropping a component of many flu vaccines because the…
STAT+: Pharmalittle: Deadline looms for drugmakers to negotiate with Medicare; GOP senator probes 340B program at two hospitals
And so, another working week will soon draw to a close. Not a moment too…
Women spend 20% more per year on out-of-pocket health costs, says report
Women of all ages pay a total of $15.4 billion more than men on annual…
STAT+: Taysha Gene Therapies’ plan to tackle rare diseases is crumbling
In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies…
Opinion: AI-driven data analysis could exacerbate misaligned incentives in biomedical research
This summer OpenAI released Code Interpreter, a plug-in for the popular ChatGPT tool that allows…
STAT+: Brigham and Women’s exec opens up about the Dana-Farber Cancer Institute split, and what it means for the future of cancer care
The severing of ties between two of Boston’s biggest health care giants has placed one…
STAT+: GOP senator probes drug discount programs at Cleveland Clinic, Bon Secours
WASHINGTON — The top ranking Republican on the Senate health committee is launching an investigation…
Listen: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump
When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech…
Exodus of life scientists from academia reaches historic levels, new data show
New data released Thursday by the National Science Foundation show the exodus of young life…
STAT+: Drug industry payments to eye docs boosted Medicare spending on pricier treatments
Ophthalmologists who accepted payments from drug companies were less likely to prescribe a cheaper medicine…
She got off dialysis. Her doctor thinks other patients with acute kidney injury can too
SAN FRANCISCO — It was during some of the darkest days of the pandemic —…
Did you have Obamacare on your GOP debate bingo card?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
Flu, Covid vaccination rates decline, as U.S. health officials make new push for inoculations
Vaccination rates against flu and Covid-19 have declined since earlier in the pandemic and a…
STAT+: Pharmalittle: FDA advisers vote overwhelmingly against ALS treatment; weight-loss drugs scrutinized over reports of suicidal thoughts
Top of the morning to you, and a fine one it is. Despite overcast skies,…
Machine learning could help predict risk of preterm birth using wearables data
For all their potential to drive changes in health, wearables have struggled to gain a…
Opinion: Congress could stop free public access to government-funded research
Have you ever needed to read a research paper, only to find it was locked…
STAT+: What will Novo’s VC do with its influx of cash? Don’t expect obesity investments
The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the…
A STAT analysis shows how top drug companies are starting to take action on climate
This article is adapted from STAT’s exclusive analysis in the STAT Report: “Climate rankings: How top…
Did the government get a bad deal on the Covid-19 boosters?
WASHINGTON — After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year,…
STAT+: 6 ways the government could help address drug shortages, including in cancer
WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing…
Republicans aren’t quite done talking about Obamacare, after all
WASHINGTON — In a far-ranging debate that touched on everything from border control issues to…
STAT+: FDA advisers vote overwhelmingly against ALS treatment from BrainStorm
A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a…
STAT+: U.S. government’s next-gen Covid effort gives small biotech up to $433 million
The U.S. government’s “Project Nextgen,” its effort to accelerate and streamline the rapid development of…
Gene therapy death was caused by an unknown risk of the virus used, study suggests
Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment…
STAT+: Biogen shutters digital health group, nixes Apple study, as part of cost cuts
Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person…
STAT+: Senate committee chair tries to spark negotiations to keep Medicare solvent
WASHINGTON — The Senate Budget Committee started what could become a bipartisan effort to extend…
Octopus tentacles inspired a new drug delivery patch that sticks to the inside of your cheek
The story of the latest development in drug administration technology — a mouth patch that…
Children of color and from low-income families disproportionately harmed by toxic chemicals, study finds
Children are often exposed to harmful chemicals in air, water, soil, food, food packaging, and…
STAT+: Pharmalittle: Pharma would lose loyal ally if Menendez leaves Senate; EMA to discuss anesthesia risk for weight-loss drugs
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Over-the-counter Sudafed doesn’t work. Neither does our system for evaluating older drugs
You would have been forgiven for being surprised on Sept. 12 when a panel of…
STAT+: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story
On a mild May day in 1993, about 60 scientists and doctors gathered on a…
STAT+: Bubble bursts: 2021 health tech IPOs and SPACs lose value, burn cash
In less than two years, digital health’s high-flying class of public debuts have landed with…
Opinion: Paxlovid is not fully accessible to those who need it most: the immunocompromised
The pandemic is over for most of the world. But for the 2.7% of adults…
Women face host of disadvantages in cancer prevention and care, report finds
Patriarchy isn’t a word that Ophira Ginsburg expected to be at the center of her…
STAT+: ARPA-H finally settles on its headquarters: hubs in Boston, Texas, and D.C.
WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research…
STAT+: Just how much money do drugmakers gain from patent extensions?
Extending patent protection doesn’t just stretch a drug’s profits — in some cases, doing so…
STAT+: With Menendez indictment, pharmaceutical industry could lose a key ally
WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry…